ID26032A - Metode dan komposisi untuk menyetabilkan komposisi asetilkolin - Google Patents

Metode dan komposisi untuk menyetabilkan komposisi asetilkolin

Info

Publication number
ID26032A
ID26032A IDW20002105A ID20002105A ID26032A ID 26032 A ID26032 A ID 26032A ID W20002105 A IDW20002105 A ID W20002105A ID 20002105 A ID20002105 A ID 20002105A ID 26032 A ID26032 A ID 26032A
Authority
ID
Indonesia
Prior art keywords
acetylcholine
buffered
stabilizing
acetic
compositions
Prior art date
Application number
IDW20002105A
Other languages
English (en)
Inventor
Fu-Pao Tsao
George Edward Minno
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID26032A publication Critical patent/ID26032A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerisation Methods In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
IDW20002105A 1998-04-29 1999-04-27 Metode dan komposisi untuk menyetabilkan komposisi asetilkolin ID26032A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6955298A 1998-04-29 1998-04-29

Publications (1)

Publication Number Publication Date
ID26032A true ID26032A (id) 2000-11-16

Family

ID=22089751

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002105A ID26032A (id) 1998-04-29 1999-04-27 Metode dan komposisi untuk menyetabilkan komposisi asetilkolin

Country Status (25)

Country Link
US (1) US6261546B1 (id)
EP (1) EP1073413B1 (id)
JP (1) JP2002512945A (id)
KR (1) KR100617429B1 (id)
CN (1) CN1147289C (id)
AT (1) ATE286380T1 (id)
AU (1) AU745124B2 (id)
BR (1) BR9910077A (id)
CA (1) CA2327398C (id)
CZ (1) CZ301969B6 (id)
DE (1) DE69923063T2 (id)
EE (1) EE04515B1 (id)
ES (1) ES2235486T3 (id)
HK (1) HK1034204A1 (id)
HU (1) HU226104B1 (id)
ID (1) ID26032A (id)
IL (1) IL138775A0 (id)
NO (1) NO20005372D0 (id)
NZ (1) NZ507074A (id)
PL (1) PL194092B1 (id)
PT (1) PT1073413E (id)
RU (1) RU2225199C2 (id)
SI (1) SI1073413T1 (id)
UA (1) UA72209C2 (id)
WO (1) WO1999055304A1 (id)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200823211A (en) 2006-11-30 2008-06-01 Nihon Mediphysics Co Ltd Novel compound having affinity for amyloid
US20130029919A1 (en) * 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009892A (en) * 1989-03-03 1991-04-23 Mckinzie James W Rapid miosis with control of intraocular pressure
US5565188A (en) 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber

Also Published As

Publication number Publication date
HUP0100613A3 (en) 2001-12-28
PL194092B1 (pl) 2007-04-30
CN1147289C (zh) 2004-04-28
ES2235486T3 (es) 2005-07-01
PL343174A1 (en) 2001-07-30
HK1034204A1 (en) 2001-10-19
EE200000625A (et) 2002-02-15
PT1073413E (pt) 2005-04-29
EP1073413B1 (en) 2005-01-05
EP1073413A1 (en) 2001-02-07
CZ301969B6 (cs) 2010-08-18
IL138775A0 (en) 2001-10-31
CZ20003961A3 (cs) 2001-01-17
WO1999055304A1 (en) 1999-11-04
KR20010043121A (ko) 2001-05-25
SI1073413T1 (id) 2005-08-31
RU2225199C2 (ru) 2004-03-10
HUP0100613A2 (hu) 2001-08-28
US6261546B1 (en) 2001-07-17
JP2002512945A (ja) 2002-05-08
CA2327398C (en) 2008-12-30
CA2327398A1 (en) 1999-11-04
UA72209C2 (en) 2005-02-15
DE69923063T2 (de) 2005-12-22
KR100617429B1 (ko) 2006-08-30
CN1298295A (zh) 2001-06-06
HU226104B1 (en) 2008-04-28
BR9910077A (pt) 2000-12-26
NO20005372L (no) 2000-10-25
NZ507074A (en) 2004-02-27
DE69923063D1 (de) 2005-02-10
NO20005372D0 (no) 2000-10-25
EE04515B1 (et) 2005-08-15
ATE286380T1 (de) 2005-01-15
AU745124B2 (en) 2002-03-14
AU4034099A (en) 1999-11-16

Similar Documents

Publication Publication Date Title
WO1995000501A3 (en) Phenyl heterocycles as cyclooxygenase-2 inhibitors
DK0677039T3 (da) Cyclobutanderivater som squalen-syntetase- og protein-farnesyltransferaseinhibitorer
MXPA02008072A (es) Composicion farmaceutica.
CA2200195A1 (en) Use of aromatase inhibitors for the production of a pharmaceutical agentfor treating a relative androgen deficiency in men
DK1273299T3 (da) Minoxidilinindeholdende praparater
KR960013371A (ko) 약학적 혼합물
WO2002008217A3 (en) COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
DE60024414T2 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
WO2002028829A3 (en) Peptide deformylase inhibitors
WO2001091738A3 (en) Naaladase inhibitors for treating amyotrophic lateral sclerosis
JO1696B1 (en) Acetamide derivatives
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
DE69614824T2 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
CA2218663A1 (en) Benzisoxazole and indazole derivatives as antipsychotic agents
ID26032A (id) Metode dan komposisi untuk menyetabilkan komposisi asetilkolin
DE69829963D1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
ES2111272T3 (es) Mezclas herbicidas.
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
BR9712851A (pt) Composições farmacêuticas compreendendo derivados de salquilisotiourÈnio
ATE299375T1 (de) Dextrinhaltige zusammensetzungen zur vermeidung von adhäsionen
DE69615397D1 (de) Heterocyclische verbindungen zur behandlung von neurogener entzündung
EA199700045A1 (ru) ЭПИМЕРЫ (22RS)-N-(1,1,1-ТРИФТОР-2-ФЕНИЛПРОП-2-ИЛ)-3-ОКСО-4-АЗА-5α-АНДРОСТ-1-ЕН-17β-КАРБОКСАМИДА
AU5662996A (en) Compounds and compositions for delivering active agents
RU95106624A (ru) Гидроксиэтиламиносульфонамиды, промежуточные соединения, фармацевтическая композиция, способ ингибирования ретровирусных протеаз, способ лечения ретровирусных инфекций, способ лечения спида